It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

vaccinations

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Brazil says Chinese vaccine trial can resume after suspension

World / Science & Health Nov 12, 2020

Brazil says Chinese vaccine trial can resume after suspension

Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage Brazilian clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide. Brazilian medical institute Butantan said in a statement ...

Brazil halts trial of Chinese vaccine. But was science or politics to blame?

World Nov 11, 2020

Brazil halts trial of Chinese vaccine. But was science or politics to blame?

by Sui-lee Wee and Ernesto Londono

Brazil's health regulator provided little information on its decision to suspend the trial, including whether a reported adverse reaction was related to the vaccine.

Why Pfizer’s vaccine won't be at the local pharmacy anytime soon

World / Science & Health | FOCUS Nov 10, 2020

Why Pfizer’s vaccine won't be at the local pharmacy anytime soon

by Carl O'Donnell

The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.

China vaccine trial halted in Brazil after serious adverse event

World / Science & Health Nov 10, 2020

China vaccine trial halted in Brazil after serious adverse event

The final-stage trial of a Chinese front-runner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nation’s rapidly developed COVID-19 shots have met with such a setback. Testing of Sinovac Biotech Ltd.’s vaccine, ...

Japan to prioritize older people in administering coronavirus vaccines

National / Science & Health Nov 10, 2020

Japan to prioritize older people in administering coronavirus vaccines

The government plans to distribute coupons for free vaccinations in order of priority when a vaccine is ready, according to the Ministry of Health, Labor and Welfare.

Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle

World / Science & Health Nov 10, 2020

Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle

The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.

China’s race for COVID-19 vaccine raises safety questions

Asia Pacific / Science & Health Nov 4, 2020

China’s race for COVID-19 vaccine raises safety questions

Process has been unhindered by common scientific setbacks being reported by Western rivals, raising questions about how stringently they are vetting potential issues.

Takeda plans to supply 50 million doses of Moderna vaccine in Japan

National / Science & Health Oct 29, 2020

Takeda plans to supply 50 million doses of Moderna vaccine in Japan

Takeda Pharmaceutical Co. said Thursday it plans to supply 50 million doses of a coronavirus vaccine, developed by U.S. drugmaker Moderna Inc., in Japan from the first half of next year. The Japanese drugmaker said it will provide the vaccine based on a three-way agreement ...

Japan's Shionogi readies COVID-19 vaccine for December trial

National / Science & Health Oct 29, 2020

Japan's Shionogi readies COVID-19 vaccine for December trial

by Rocky Swift

The firm plans to put its vaccine candidate into Phase 1 clinical trials in December and shift into Phase 2 by January.

Japan approves bill to offer all residents free COVID-19 vaccines

National / Science & Health Oct 27, 2020

Japan approves bill to offer all residents free COVID-19 vaccines

With a budget of ¥671.4 billion, deals have been struck with AstraZeneca PLC and Pfizer Inc. for 120 million doses from each. Negotiations with Moderna Inc. are ongoing.

Getting vaccine doubters to roll up their sleeves won’t be easy

World | FOCUS Oct 19, 2020

Getting vaccine doubters to roll up their sleeves won’t be easy

by James Paton and Sybilla Gross

Fading trust in governments, political interference and the dash to create a shot in record time are sowing doubts.

WHO coronavirus vaccine drive bedeviled by familiar question: Who pays if things go wrong?

World / Science & Health Oct 17, 2020

WHO coronavirus vaccine drive bedeviled by familiar question: Who pays if things go wrong?

Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in the battle to beat COVID-19. The World Health Organization has so far left the question of financial claims unresolved ...

« 1 … 66 67 68 … 74 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times